Shares in ECR Minerals (AIM: ECR) have fallen to around 0.14p, near their 52-week low, despite a series of announcements pointing to operational progress across its Australian gold projects. For
Shares in ECR Minerals (AIM: ECR) have fallen to around 0.14p, near their 52-week low, despite a series of announcements pointing to operational progress across its Australian gold projects. For
ECR Minerals plc (AIM: ECR) has reported further progress at its Maddens Flat gold project in North Queensland, Australia, with the processing plant now commissioned and operational ahead of planned
The FTSE 100 closed 1.06% higher at 10,552.05 on Friday, while the FTSE 250 gained 1.13% to 24,213.78. The rebound followed a volatile week dominated by oil prices, inflation concerns
Coarse Gold Discovery at Brothers Creek 12.3g Nugget Highlights Gold Fertility and Emerging Alluvial Opportunity
ECR Minerals plc (AIM: ECR) has renegotiated the A$2 million deferred consideration for its 50% interest in the Maddens Gold Project, replacing a fixed November 2026 payment with one linked
ECR Minerals plc (LON: ECR) has appointed Mike McRae-Williams as Operations Manager for Australia as the company prepares for increased activity across its Australian gold portfolio.
ECR Minerals (AIM: ECR) has reported encouraging new soil sampling results from its 100%-owned Lolworth Project in North Queensland, with the latest data pointing towards a potentially much broader gold-bearing
ECR Minerals (ECR LN) 0.16p, Mkt Cap £6.6m – New gold-bearing reef found underground at Maddens in Australia
ECR Minerals plc (AIM: ECR) has identified a new visible gold-bearing quartz reef at the Maddens Gold Project in North Queensland, potentially opening up a significant new exploration opportunity around
ECR Minerals plc (AIM: ECR) has executed binding conditional farm-in and joint venture agreements with Bold Gold Resources, providing a pathway for up to A$3 million of third-party exploration investment
The FTSE 100 extended its losing streak to a fifth consecutive session on Friday, falling 22.56 points, or 0.2%, to close at 10,750.11, as weakness among miners and pharmaceutical heavyweights
Institutional investor increases participation with additional £0.25 million investment